Fresenius Medical Care AG (FMS)

NYQ – Real vaqt narxi. Valyuta: USD

23.24

-0.01 (-0.04%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

23.69

+0.45 (1.94%)

Bozordan keyin: Jun 26, 2026, 6:40 PM EDT

15.06.2026

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

Hydrogeological Assessment Concludes Multi-Year Environmental Program and Supports Upcoming ESIA Submission Ottawa, Ontario--(Newsfile Corp. - June 15, 2026) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company") a Canadian developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce the completion of the Hydrogeological Assessment (the "Assessment" or the "Study") for its wholly-owned Lac Knife Graphite Project ("Lac Knife" or the "Project"), concluding a multi-year environmental program and completing the major technical work required to support the Company's Environmental and Social Impact Assessment ("ESIA") submission. Completed by Yves Leblanc, P.Geo.

08.06.2026

FMS and Home Dialysis: How 5008X Could Reset Demand

FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.

05.06.2026

FMS Launches kinexus Digital Platform for Home Dialysis Care

Fresenius Medical Care launches kinexus, a home dialysis platform integrating remote monitoring, prescription management and supply ordering for PD and HHD.

03.06.2026

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Global launch of a single, integrated digital platform connecting remote therapy monitoring and operational workflows for home dialysis programs Designed to simplify care processes for healthcare teams and their patients to support high-quality, personalized care for patients dialyzing at home Enables managing peritoneal dialysis and home hemodialysis therapies across Fresenius Medical Care's global home dialysis portfolio in one digital platform BAD HOMBURG, Germany, June 3, 2026 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the global launch of kinexus, a unified digital platform designed to support home dialysis programs and strengthen connected, patient-centered care. With kinexus, Fresenius Medical Care (FME) is advancing connected home dialysis care by bringing together digital modules supporting peritoneal dialysis (PD) and home hemodialysis (HHD) within a single, unified platform.

28.05.2026

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

BAD HOMBURG, Germany, May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch of the first tranche of its new share buyback program with a total volume of around EUR 1 billion. The first tranche, amounting up to EUR 600 million, was initiated today and is expected to be completed by December 15, 2026.

27.05.2026

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Hemodiafiltration (HDF) research reinforces Fresenius Medical Care's continued leadership in advancing evidence-based dialysis care and treatment personalization New research focuses on applying real-world evidence, patient-centered outcomes and artificial intelligence across dialysis modalities and continuity of kidney care A preview of kinexus, a unified digital platform intended to support home dialysis programs by connecting therapy management and care workflows BAD HOMBURG, Germany, May 27, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, presents new research highlighting ongoing innovation at the European Renal Association (ERA) Congress 2026, June 3-6 in Glasgow, Scotland, and virtually. The Company highlights advancements including new hemodiafiltration research that reaffirm its leadership in evidence based and personalized dialysis care, real-world evidence to strengthen patient centered outcomes across dialysis modalities, and the application of artificial intelligence (AI) to improve patient outcomes.

26.05.2026

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Total volume of the share buyback is around EUR 1 billion over 12 months Share buyback expected to begin in the near future BAD HOMBURG, Germany, May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, intends to execute a new share buyback program with a total volume of around EUR 1 billion. The program shall be executed in tranches over a period of 12 months from its start.

Videolar

No Data

There is no data to display

Press-relizlar

15.06.2026

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

03.06.2026

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

28.05.2026

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

27.05.2026

Fresenius Medical Care AG (FMS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Fresenius Medical Care AG (FMS)

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

FMS and Home Dialysis: How 5008X Could Reset Demand

FMS Launches kinexus Digital Platform for Home Dialysis Care

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Videolar

No Data

Press-relizlar

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

FMS and Home Dialysis: How 5008X Could Reset Demand

FMS Launches kinexus Digital Platform for Home Dialysis Care

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Videolar

No Data

Press-relizlar

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Search stocks

Fresenius Medical Care AG (FMS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Fresenius Medical Care AG (FMS)

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

FMS and Home Dialysis: How 5008X Could Reset Demand

FMS Launches kinexus Digital Platform for Home Dialysis Care

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Videolar

No Data

Press-relizlar

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

FMS and Home Dialysis: How 5008X Could Reset Demand

FMS Launches kinexus Digital Platform for Home Dialysis Care

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Videolar

No Data

Press-relizlar

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026